These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
55. Future forms of immunotherapy. Casale TB; Stokes JR J Allergy Clin Immunol; 2011 Jan; 127(1):8-15; quiz 16-7. PubMed ID: 21094518 [TBL] [Abstract][Full Text] [Related]
56. Certainties and doubts about sublingual and oral immunotherapy in children. Larenas-Linnemann D Curr Opin Allergy Clin Immunol; 2009 Dec; 9(6):558-67. PubMed ID: 19812482 [TBL] [Abstract][Full Text] [Related]
57. [Role of allergen-specific immunotherapy (desensitization) for the treatment of allergies in Germany. Current situation]. Kleine-Tebbe J; Ackermann-Simon J; Hanf G Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 Mar; 55(3):343-50. PubMed ID: 22373847 [TBL] [Abstract][Full Text] [Related]
58. Meta-analyses of specific immunotherapy trials. Calderon MA Drugs Today (Barc); 2008 Dec; 44 Suppl B():31-4. PubMed ID: 19221615 [No Abstract] [Full Text] [Related]
59. Systemic tolerability of specific subcutaneous immunotherapy with index-of-reactivity-standardized allergen extracts administered using clustered regimens: a retrospective, observational, multicenter study. Serrano P; Justicia JL; Sánchez C; Cimarra M; Fernández-Távora L; Orovitg A; Moreno C; Guerra F; Alvà V Ann Allergy Asthma Immunol; 2009 Mar; 102(3):247-52. PubMed ID: 19354072 [TBL] [Abstract][Full Text] [Related]